The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies
Investors understand that their principal will be at very high risk
Category
Sector Funds
Launch Date
05-Jun-04
Scheme Benchmark
S&P BSE HEALTH CARE - TRI
AUM ( in Cr.)
4,267.60
portfolio price to book value
5.3
investing style?
Large Growth
fund manager?
Sailesh Raj Bhan,Kinjal Desai
inception date (regular plan)
expense ratio (regular plan) %
2.00